EU CHMP Opinions And MAA Updates

Recommendations by the European Medicines Agency’s human medicines committee (the CHMP) on the authorization of new medicines in the EU and updates on marketing authorization changes recommended by the CHMP. Updated monthly.

The CHMP meets once a month to review marketing applications as part of the EU’s centralized marketing procedure. CHMP opinions are sent to the European Commission, which makes a final, legally binding decision, usually within 67 days.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?